| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AGENT makes cyanide a useful killer
|
Senior, Kathryn
|
|
|
7 |
5 |
p. 278-279
|
artikel
|
| 2 |
Akubio: label-free screening of molecular interactions using acoustic detection
|
Cooper, Matthew A
|
|
|
7 |
5 |
p. S5-S7
|
artikel
|
| 3 |
Archemix: drug discovery innovation based on evolutionary nucleic acid technology platforms
|
Epstein, David
|
|
|
7 |
5 |
p. S8-S11
|
artikel
|
| 4 |
A succulent cure to end obesity
|
Habeck, Martina
|
|
|
7 |
5 |
p. 280-281
|
artikel
|
| 5 |
Chemical genomics: discovery of disease genes and drugs
|
Alaoui-Ismaili, Moulay H
|
|
|
7 |
5 |
p. 292-294
|
artikel
|
| 6 |
Current themes in microarray experimental design and analysis
|
Foster, William R
|
|
|
7 |
5 |
p. 290-292
|
artikel
|
| 7 |
Cytokine inhibition: a new therapeutic avenue for skeletal diseases
|
Hofbauer, Lorenz C
|
|
|
7 |
5 |
p. 289
|
artikel
|
| 8 |
Discovering the potential of drug discovery
|
Tong, Jeffrey K
|
|
|
7 |
5 |
p. S3-S4
|
artikel
|
| 9 |
Drug delivery: A drug-loaded tumor cell system for lung targeting
|
Weidner, John
|
|
|
7 |
5 |
p. 326-327
|
artikel
|
| 10 |
Drug-induced islet growth: a novel treatment for diabetes?
|
Whelan, Jo
|
|
|
7 |
5 |
p. 277-278
|
artikel
|
| 11 |
Editorial: top-ten start-up companies of 2001
|
Lawrence, Rebecca
|
|
|
7 |
5 |
p. S1-S2
|
artikel
|
| 12 |
Elitra pharmaceuticals: new paradigms for antimicrobial drug discovery
|
Foulkes, J.Gordon
|
|
|
7 |
5 |
p. S12-S15
|
artikel
|
| 13 |
Erratum
|
Owens, J
|
|
|
7 |
5 |
p. 289
|
artikel
|
| 14 |
Formulating fortunes – the tale of a medicated lozenge
|
Rowe, Raymond C
|
|
|
7 |
5 |
p. 286-287
|
artikel
|
| 15 |
Is telomerase the cure-all and end-all?
|
Holt, Shawn E
|
|
|
7 |
5 |
p. 288
|
artikel
|
| 16 |
Locus Discovery: from structure to hit in weeks
|
Eringis, Dawn
|
|
|
7 |
5 |
p. S16-S18
|
artikel
|
| 17 |
Lorantis: creating new medicines for selective treatment of immunological diseases
|
Bodmer, Mark
|
|
|
7 |
5 |
p. S19-S21
|
artikel
|
| 18 |
Metris Therapeutics: a pharmaceutical focus on gynaecology
|
Knox, Peter
|
|
|
7 |
5 |
p. S22-S24
|
artikel
|
| 19 |
Micromet: engaging immune cells for life
|
Wolf, Evelyn
|
|
|
7 |
5 |
p. S25-S27
|
artikel
|
| 20 |
Monitor: molecules and profiles
|
Barrett, David
|
|
|
7 |
5 |
p. 324-326
|
artikel
|
| 21 |
Morphochem: breeding small molecules
|
Weber, Lutz
|
|
|
7 |
5 |
p. S28-S31
|
artikel
|
| 22 |
New opportunities in toxicology in the post-genomic era
|
Olden, Kenneth
|
|
|
7 |
5 |
p. 273-276
|
artikel
|
| 23 |
News in brief
|
Clough, Joanne
|
|
|
7 |
5 |
p. 281-284
|
artikel
|
| 24 |
People
|
Lawrence, Rebecca N
|
|
|
7 |
5 |
p. 284-285
|
artikel
|
| 25 |
Picoliter: enabling precise transfer of nanoliter and picoliter volumes
|
Ellson, Richard
|
|
|
7 |
5 |
p. S32-S34
|
artikel
|
| 26 |
Stem cells: hype or hope?
|
Paul, Gesine
|
|
|
7 |
5 |
p. 295-302
|
artikel
|
| 27 |
Stereoselective synthesis from a process research perspective
|
Hillier, Michael C
|
|
|
7 |
5 |
p. 303-314
|
artikel
|
| 28 |
The evolving role of information technology in the drug discovery process
|
Augen, Jeffrey
|
|
|
7 |
5 |
p. 315-323
|
artikel
|
| 29 |
Triad Therapeutics: integration of NMR structural determinations and smart chemistry to speed drug discovery
|
Jack, Richard M.
|
|
|
7 |
5 |
p. S35-S38
|
artikel
|
Tijdschrift beschrijving